NorthWest Biotherapeutics Inc (NWBO)

[Roman516]

H-G, but the reality is that the Regulators already understand that DCVax-L does in fact work and it has already been proven multiple times. In fact, DCVax-L has virtually zero side effects compared to vast array of side effects from current treatment products like the high frequency transducer helmet, IMPO. All the best!
Perhaps when DCVax-L is approved, the NCCN will consider designated DCVax-L as the new first line therapy, IMPO. [color=red][/color]